Selected research
Market Analysis & Forecast
Global Butorphanol Market Analysis and Forecast 2026-2032
Market perspective
The global Butorphanol market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Butorphanol is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Butorphanol is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Butorphanol is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Butorphanol is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Butorphanol include Zoetis, Merck KGaA, Mylan, Pfizer, Troy Laboratories Nz, Selectavet, Sanochemia Pharmazeutika, Richter Pharma Ag and Novex Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Butorphanol, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Butorphanol, also provides the sales of main regions and countries. Of the upcoming market potential for Butorphanol, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Butorphanol sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Butorphanol market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Butorphanol sales, projected growth trends, production technology, application and end-user industry.
Butorphanol Segment by Company
Zoetis
Merck KGaA
Mylan
Pfizer
Troy Laboratories Nz
Selectavet
Sanochemia Pharmazeutika
Richter Pharma Ag
Novex Pharma
Hikma Pharmaceuticals
Faunapharma
Dechra Pharmaceuticals
Bristol Myers Squibb
Boehringer Ingelheim Santé Animale
Ausrichter
Athanas Enterprise Private Limited
Apothecon Pharmaceuticals
Animedica
Butorphanol Segment by Type
Injection
Spray
Tablet
Butorphanol Segment by Application
Human
Veterinary
Butorphanol Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Butorphanol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Butorphanol and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Butorphanol.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Butorphanol in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Butorphanol manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Butorphanol sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Injection
- Spray
- Tablet
Applications
- Human
- Veterinary
Companies covered
- Zoetis
- Merck KGaA
- Mylan
- Pfizer
- Troy Laboratories Nz
- Selectavet
- Sanochemia Pharmazeutika
- Richter Pharma Ag
- Novex Pharma
- Hikma Pharmaceuticals
- Faunapharma
- Dechra Pharmaceuticals
- Bristol Myers Squibb
- Boehringer Ingelheim Santé Animale
- Ausrichter
- Athanas Enterprise Private Limited
- Apothecon Pharmaceuticals
- Animedica
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Butorphanol Market by Type
- 1.2.1 Global Butorphanol Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Injection
- 1.2.3 Spray
- 1.2.4 Tablet
- 1.3 Butorphanol Market by Application
- 1.3.1 Global Butorphanol Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Human
- 1.3.3 Veterinary
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Butorphanol Market Dynamics
- 2.1 Butorphanol Industry Trends
- 2.2 Butorphanol Industry Drivers
- 2.3 Butorphanol Industry Opportunities and Challenges
- 2.4 Butorphanol Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Butorphanol Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Butorphanol Revenue by Region
- 3.2.1 Global Butorphanol Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Butorphanol Revenue by Region (2021-2026)
- 3.2.3 Global Butorphanol Revenue by Region (2027-2032)
- 3.2.4 Global Butorphanol Revenue Market Share by Region (2021-2032)
- 3.3 Global Butorphanol Sales Estimates and Forecasts 2021-2032
- 3.4 Global Butorphanol Sales by Region
- 3.4.1 Global Butorphanol Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Butorphanol Sales by Region (2021-2026)
- 3.4.3 Global Butorphanol Sales by Region (2027-2032)
- 3.4.4 Global Butorphanol Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Butorphanol Revenue by Manufacturers
- 4.1.1 Global Butorphanol Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Butorphanol Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Butorphanol Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Butorphanol Sales by Manufacturers
- 4.2.1 Global Butorphanol Sales by Manufacturers (2021-2026)
- 4.2.2 Global Butorphanol Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Butorphanol Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Butorphanol Sales Price by Manufacturers (2021-2026)
- 4.4 Global Butorphanol Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Butorphanol Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Butorphanol Manufacturers, Product Type & Application
- 4.7 Global Butorphanol Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Butorphanol Market CR5 and HHI
- 4.8.2 2025 Butorphanol Tier 1, Tier 2, and Tier 3
5 Butorphanol Market by Type
- 5.1 Global Butorphanol Revenue by Type
- 5.1.1 Global Butorphanol Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Butorphanol Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Butorphanol Revenue Market Share by Type (2021-2032)
- 5.2 Global Butorphanol Sales by Type
- 5.2.1 Global Butorphanol Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Butorphanol Sales by Type (2021-2032) & (K Units)
- 5.2.3 Global Butorphanol Sales Market Share by Type (2021-2032)
- 5.3 Global Butorphanol Price by Type
6 Butorphanol Market by Application
- 6.1 Global Butorphanol Revenue by Application
- 6.1.1 Global Butorphanol Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Butorphanol Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Butorphanol Revenue Market Share by Application (2021-2032)
- 6.2 Global Butorphanol Sales by Application
- 6.2.1 Global Butorphanol Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Butorphanol Sales by Application (2021-2032) & (K Units)
- 6.2.3 Global Butorphanol Sales Market Share by Application (2021-2032)
- 6.3 Global Butorphanol Price by Application
7 Company Profiles
- 7.1 Zoetis
- 7.1.1 Zoetis Company Information
- 7.1.2 Zoetis Business Overview
- 7.1.3 Zoetis Butorphanol Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Zoetis Butorphanol Product Portfolio
- 7.1.5 Zoetis Recent Developments
- 7.2 Merck KGaA
- 7.2.1 Merck KGaA Company Information
- 7.2.2 Merck KGaA Business Overview
- 7.2.3 Merck KGaA Butorphanol Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Merck KGaA Butorphanol Product Portfolio
- 7.2.5 Merck KGaA Recent Developments
- 7.3 Mylan
- 7.3.1 Mylan Company Information
- 7.3.2 Mylan Business Overview
- 7.3.3 Mylan Butorphanol Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Mylan Butorphanol Product Portfolio
- 7.3.5 Mylan Recent Developments
- 7.4 Pfizer
- 7.4.1 Pfizer Company Information
- 7.4.2 Pfizer Business Overview
- 7.4.3 Pfizer Butorphanol Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Pfizer Butorphanol Product Portfolio
- 7.4.5 Pfizer Recent Developments
- 7.5 Troy Laboratories Nz
- 7.5.1 Troy Laboratories Nz Company Information
- 7.5.2 Troy Laboratories Nz Business Overview
- 7.5.3 Troy Laboratories Nz Butorphanol Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Troy Laboratories Nz Butorphanol Product Portfolio
- 7.5.5 Troy Laboratories Nz Recent Developments
- 7.6 Selectavet
- 7.6.1 Selectavet Company Information
- 7.6.2 Selectavet Business Overview
- 7.6.3 Selectavet Butorphanol Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Selectavet Butorphanol Product Portfolio
- 7.6.5 Selectavet Recent Developments
- 7.7 Sanochemia Pharmazeutika
- 7.7.1 Sanochemia Pharmazeutika Company Information
- 7.7.2 Sanochemia Pharmazeutika Business Overview
- 7.7.3 Sanochemia Pharmazeutika Butorphanol Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Sanochemia Pharmazeutika Butorphanol Product Portfolio
- 7.7.5 Sanochemia Pharmazeutika Recent Developments
- 7.8 Richter Pharma Ag
- 7.8.1 Richter Pharma Ag Company Information
- 7.8.2 Richter Pharma Ag Business Overview
- 7.8.3 Richter Pharma Ag Butorphanol Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Richter Pharma Ag Butorphanol Product Portfolio
- 7.8.5 Richter Pharma Ag Recent Developments
- 7.9 Novex Pharma
- 7.9.1 Novex Pharma Company Information
- 7.9.2 Novex Pharma Business Overview
- 7.9.3 Novex Pharma Butorphanol Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Novex Pharma Butorphanol Product Portfolio
- 7.9.5 Novex Pharma Recent Developments
- 7.10 Hikma Pharmaceuticals
- 7.10.1 Hikma Pharmaceuticals Company Information
- 7.10.2 Hikma Pharmaceuticals Business Overview
- 7.10.3 Hikma Pharmaceuticals Butorphanol Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 Hikma Pharmaceuticals Butorphanol Product Portfolio
- 7.10.5 Hikma Pharmaceuticals Recent Developments
- 7.11 Faunapharma
- 7.11.1 Faunapharma Company Information
- 7.11.2 Faunapharma Business Overview
- 7.11.3 Faunapharma Butorphanol Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.11.4 Faunapharma Butorphanol Product Portfolio
- 7.11.5 Faunapharma Recent Developments
- 7.12 Dechra Pharmaceuticals
- 7.12.1 Dechra Pharmaceuticals Company Information
- 7.12.2 Dechra Pharmaceuticals Business Overview
- 7.12.3 Dechra Pharmaceuticals Butorphanol Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.12.4 Dechra Pharmaceuticals Butorphanol Product Portfolio
- 7.12.5 Dechra Pharmaceuticals Recent Developments
- 7.13 Bristol Myers Squibb
- 7.13.1 Bristol Myers Squibb Company Information
- 7.13.2 Bristol Myers Squibb Business Overview
- 7.13.3 Bristol Myers Squibb Butorphanol Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.13.4 Bristol Myers Squibb Butorphanol Product Portfolio
- 7.13.5 Bristol Myers Squibb Recent Developments
- 7.14 Boehringer Ingelheim Santé Animale
- 7.14.1 Boehringer Ingelheim Santé Animale Company Information
- 7.14.2 Boehringer Ingelheim Santé Animale Business Overview
- 7.14.3 Boehringer Ingelheim Santé Animale Butorphanol Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.14.4 Boehringer Ingelheim Santé Animale Butorphanol Product Portfolio
- 7.14.5 Boehringer Ingelheim Santé Animale Recent Developments
- 7.15 Ausrichter
- 7.15.1 Ausrichter Company Information
- 7.15.2 Ausrichter Business Overview
- 7.15.3 Ausrichter Butorphanol Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.15.4 Ausrichter Butorphanol Product Portfolio
- 7.15.5 Ausrichter Recent Developments
- 7.16 Athanas Enterprise Private Limited
- 7.16.1 Athanas Enterprise Private Limited Company Information
- 7.16.2 Athanas Enterprise Private Limited Business Overview
- 7.16.3 Athanas Enterprise Private Limited Butorphanol Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.16.4 Athanas Enterprise Private Limited Butorphanol Product Portfolio
- 7.16.5 Athanas Enterprise Private Limited Recent Developments
- 7.17 Apothecon Pharmaceuticals
- 7.17.1 Apothecon Pharmaceuticals Company Information
- 7.17.2 Apothecon Pharmaceuticals Business Overview
- 7.17.3 Apothecon Pharmaceuticals Butorphanol Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.17.4 Apothecon Pharmaceuticals Butorphanol Product Portfolio
- 7.17.5 Apothecon Pharmaceuticals Recent Developments
- 7.18 Animedica
- 7.18.1 Animedica Company Information
- 7.18.2 Animedica Business Overview
- 7.18.3 Animedica Butorphanol Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.18.4 Animedica Butorphanol Product Portfolio
- 7.18.5 Animedica Recent Developments
8 North America
- 8.1 North America Butorphanol Market Size by Type
- 8.1.1 North America Butorphanol Revenue by Type (2021-2032)
- 8.1.2 North America Butorphanol Sales by Type (2021-2032)
- 8.1.3 North America Butorphanol Price by Type (2021-2032)
- 8.2 North America Butorphanol Market Size by Application
- 8.2.1 North America Butorphanol Revenue by Application (2021-2032)
- 8.2.2 North America Butorphanol Sales by Application (2021-2032)
- 8.2.3 North America Butorphanol Price by Application (2021-2032)
- 8.3 North America Butorphanol Market Size by Country
- 8.3.1 North America Butorphanol Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Butorphanol Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Butorphanol Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
9 Europe
- 9.1 Europe Butorphanol Market Size by Type
- 9.1.1 Europe Butorphanol Revenue by Type (2021-2032)
- 9.1.2 Europe Butorphanol Sales by Type (2021-2032)
- 9.1.3 Europe Butorphanol Price by Type (2021-2032)
- 9.2 Europe Butorphanol Market Size by Application
- 9.2.1 Europe Butorphanol Revenue by Application (2021-2032)
- 9.2.2 Europe Butorphanol Sales by Application (2021-2032)
- 9.2.3 Europe Butorphanol Price by Application (2021-2032)
- 9.3 Europe Butorphanol Market Size by Country
- 9.3.1 Europe Butorphanol Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Butorphanol Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Butorphanol Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Netherlands
10 China
- 10.1 China Butorphanol Market Size by Type
- 10.1.1 China Butorphanol Revenue by Type (2021-2032)
- 10.1.2 China Butorphanol Sales by Type (2021-2032)
- 10.1.3 China Butorphanol Price by Type (2021-2032)
- 10.2 China Butorphanol Market Size by Application
- 10.2.1 China Butorphanol Revenue by Application (2021-2032)
- 10.2.2 China Butorphanol Sales by Application (2021-2032)
- 10.2.3 China Butorphanol Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Butorphanol Market Size by Type
- 11.1.1 Asia Butorphanol Revenue by Type (2021-2032)
- 11.1.2 Asia Butorphanol Sales by Type (2021-2032)
- 11.1.3 Asia Butorphanol Price by Type (2021-2032)
- 11.2 Asia Butorphanol Market Size by Application
- 11.2.1 Asia Butorphanol Revenue by Application (2021-2032)
- 11.2.2 Asia Butorphanol Sales by Application (2021-2032)
- 11.2.3 Asia Butorphanol Price by Application (2021-2032)
- 11.3 Asia Butorphanol Market Size by Country
- 11.3.1 Asia Butorphanol Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Butorphanol Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Butorphanol Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Butorphanol Market Size by Type
- 12.1.1 SAMEA Butorphanol Revenue by Type (2021-2032)
- 12.1.2 SAMEA Butorphanol Sales by Type (2021-2032)
- 12.1.3 SAMEA Butorphanol Price by Type (2021-2032)
- 12.2 SAMEA Butorphanol Market Size by Application
- 12.2.1 SAMEA Butorphanol Revenue by Application (2021-2032)
- 12.2.2 SAMEA Butorphanol Sales by Application (2021-2032)
- 12.2.3 SAMEA Butorphanol Price by Application (2021-2032)
- 12.3 SAMEA Butorphanol Market Size by Country
- 12.3.1 SAMEA Butorphanol Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Butorphanol Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Butorphanol Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Butorphanol Value Chain Analysis
- 13.1.1 Butorphanol Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Butorphanol Production Mode & Process
- 13.2 Butorphanol Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Butorphanol Distributors
- 13.2.3 Butorphanol Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst